SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " pharma " 698 found 🔀 AI-powered Shuffle
PBM reforms promise relief for NC’s independent pharmacies
Federal and state actions seek transparency and fair reimbursements from pharmacy benefit managers, as rural communities lose local drugstores.
PRET for impact: Advancing pandemic preparedness in the Democratic People’s Republic of Korea
IN THE SPOTLIGHT PRET for impact: Advancing pandemic preparedness in the Democratic People’s Republic of KoreaThe Democratic People’s Republic of Korea (DPR Korea) is making significant progress in strengthening pandemic preparedness, with dedicated support from the WHO South‑East Asia Regional Office (SEARO) and the Pandemic Influenza Preparedness (PIP) Partnership Contribution (PC).Aligned with the WHO Global Influenza Strategy and the Pandemic Influenza Preparedness (PIP) Framework Partnership Contribution High‑Level Implementation Plan III (2024–2030), the country is strengthening its capacity to prepare for and respond to influenza and other respiratory threats. In early 2025, a core team from the Ministry of Public Health of the Democratic People’s Republic of Korea (DPRK) participated in a two‑day virtual workshop, which included a mini‑simulation exercise. The workshop was organized by WHO SEARO in collaboration with the Preparedness and Resilience for Emerging Threats (PRET) Secretariat at WHO headquarters and the WHO Country Office for the DPRK. Read more A REGIONAL CONSULTATION GUIDES WHO SEARO IN DEVELOPING A ROADMAP FOR IMPLEMENTING THE PREPPAREDNESS AND RESILIENCE FOR EMERGING THREATS (PRET) INITIATIVE BASED RESPIRATORY PATHOGEN PANDEMIC PREPAREDNESSInfluenza and other respiratory pathogens with pandemic potential continue to pose major public health risks globally. To strengthen regional preparedness and response, Member States of the WHO South‑East Asia Region (SEAR) convened in Colombo, Sri Lanka, to review and provide input on the draft Roadmap and Action Framework for Broad Respiratory Pathogen Pandemic Planning (2026–2031). Supported through the Pandemic Influenza Preparedness (PIP) Partnership Contribution (PC) funds, the proposed roadmap aims to advance robust, integrated preparedness and response capacities for influenza and other respiratory threats across SEAR. This work is aligned with the Preparedness and Resilience for Emerging Threats (PRET) initiative and the SEAR Strategic Roadmap on Health Security and Health System Resilience for Emergencies Read moreSRI LANKA’S USE OF ANTIVIRALS TO REDUCE THE SEASONAL INFLUENZA BURDEN Sri Lanka is strengthening its influenza response by placing greater emphasis on rapid testing, timely treatment, and integration with maternal health services. With support from WHO, the country is building a stronger evidence base on the burden of influenza and the value of vaccination, advancing a holistic approach to protect vulnerable populations and enhance pandemic preparedness. To reduce hospitalizations and deaths from seasonal influenza, Sri Lanka is taking proactive steps to expand access to rapid diagnostic testing and ensure prompt initiation of treatment. National clinical guidelines recommend the use of oseltamivir for individuals at high risk of complications, helping prevent severe illness and shorten the duration of infection. This strategy not only saves lives but also supports local pharmaceutical production, contributing to a reliable supply of antivirals for both seasonal outbreaks and future pandemics.Read moreBHUTAN BOOSTS PANDEMIC INFLUENZA READINESS WITH PANDEMIC INFLUENZA PREPAREDNESS FRAMEWORK PARTNERSHIP CONTRIBUTION SUPPORTED TRAINING AND SIMULATIONSOriginally developed in 2012, the National Influenza Pandemic Preparedness and Response Plan (NIPPRP) has long served as Bhutan’s central framework for managing influenza threats. In 2024, the plan underwent a comprehensive update to reflect evolving global and regional guidance, lessons learned from the COVID‑19 pandemic, and new capacities developed under the PIP Framework. The revised NIPPRP is now more clearly aligned with Bhutan’s broader emergency and disaster risk management structures, ensuring a coordinated, whole‑of‑government approach to pandemic response. As part of efforts to strengthen national pandemic preparedness, Bhutan conducted three national‑level training sessions followed by simulation exercises on influenza pandemic preparedness and response at five sentinel hospitals between April and May 2025, with support from the PIP Partnership Contribution (PC). These activities brought together more than 140 health professionals and key partners from across the country, with a focus on operationalizing the updated NIPPRP and enhancing readiness at key frontline facilities. Read moreSTRENGTHENING INFLUENZA SURVEILLANCE: WHO BRINGS TOGETHER INFLUENZA EXPERTS FROM SOUTH-EAST ASIA AND WESTERN PACIFIC REGIONSThe World Health Organization (WHO) convened the 18th Bi‑regional Meeting of National Influenza Centres (NICs) and Influenza Surveillance for the WHO South‑East Asia and Western Pacific Regions from 9–11 September 2025. Hosted by the WHO South‑East Asia Regional Office (SEARO), the meeting brought together representatives from Member States, Territories, and Areas across both regions, alongside experts from the WHO Collaborating Centres for Reference and Research on Influenza in Australia and Japan, the WHO Collaborating Centre for Studies on the Ecology of Influenza in Animals in the United States, quadripartite partners (WOAH and FAO), and other technical counterparts. The consultation provided a platform to review progress, share experiences, and outline priorities for strengthening influenza and respiratory pathogen surveillance across the two WHO regions.Read moreNETWORKS AND TECHNICAL PARTNERSHIPSSTRENGTHENING PANDEMIC READINES: SOUTH-EAST ASIA ADVANCES UNITY STUDIES UNDER THE PANDEMIC INFLUENZA PREPAREDNESS INITIATIVEThe WHO Global Influenza Surveillance and Response System (GISRS) Investigations & Studies initiative, also known as Unity Studies, provides a standardized, globally coordinated framework to support these efforts. Originally developed for influenza and adapted during COVID-19, Unity Studies enable countries to conduct rapid, nationally led investigations and studies to assess transmissibility, severity, susceptibility, and intervention effectiveness. To better prepare for future influenza pandemics, WHO has recently launched a network of sites which will be ready to conduct these investigations and studies rapidly in the event of a pandemic, or epidemic of an emerging or re-emerging respiratory pathogen. The WHO South-East Asia Region now hosts six sites of WHO GISRS Unity Studies across the five countries including Sri Lanka, strengthening regional capacity for early pandemic investigations. From 13–16 July 2025 in Colombo, the Global Public Health Summit offered an opportunity to advance this agenda. Read moreSTRENGTHENING PANDEMIC PREPAREDNESS THROUGH UNITY STUDIES: REAL-WORLD APPLICATIONS FROM INDIA IN WHO’S SOUTH-EAST ASIA REGION As countries continue to strengthen their pandemic preparedness through investments in resilient health systems during the interpandemic period, the World Health Organization’s (WHO) Global Influenza Surveillance and Response System (GISRS) Investigations & Studies Global Initiative, Global Initiative, commonly known as Unity Studies, remains a vital framework for respiratory pathogen pandemic preparedness. These standardized epidemiological protocols enable countries to rapidly generate high‑quality data on transmissibility, infection severity, population immunity, and the effectiveness of public health interventions. To highlight how Unity Studies protocols are being adapted and applied in national settings, WHO Headquarters, together with WHO Regional Offices, including the WHO South‑East Asia Regional Office (SEARO), hosted a global webinar. The session showcased case studies from India and the United Kingdom (UK), demonstrating innovative approaches to respiratory virus surveillance and pandemic readiness. Read moreSTRENGTHENING REGIONAL INFLUENZA SURVEILLANCE AND PREPAREDNESS: WHO SEARO HOSTS HIGH-LEVEL WEBINAR AMID RISING H5 THREATS In response to the increasing detection of avian influenza A(H5) cases in humans globally and within the WHO South‑East Asia Region, the WHO Regional Office for South‑East Asia (SEARO) convened a regional webinar on 25 July 2025 to review preparedness mechanisms, strengthen surveillance pathways, and promote timely reporting of unusual respiratory events. The virtual session brought together more than 50 participants from Ministries of Health, National Influenza Centres (NICs), National IHR Focal Points (NFPs), WHO Headquarters, WHO Country Offices across the Region, and WHO Collaborating Centres (CCs) for influenza. The webinar provided an opportunity to share situational updates, discuss surveillance gaps, and reinforce coordination mechanisms critical for early detection and rapid response to avian influenza threats. Read moreOther Key PIP Updates (July-December 2025)MEMBER STATES:Bangladesh drafted and conducted a series of Core Group Meetings in 2025 to review and update the National Pandemic Preparedness and Response Plan for Respiratory Pathogens. In addition, the country carried out Rapid Response Team (RRT) trainings on seasonal and avian influenza and other re‑emerging infectious diseases. Bangladesh also updated its epidemiological data‑training programme for physicians at sentinel surveillance sites, using a revised epidemiological data‑collection tool.Bhutan revised and updated its National Influenza Pandemic Preparedness and Response Plan (NIPPRP) in 2025 and developed a national Standard Operating Procedure (SOP) for influenza outbreak management. DPR Korea conducted a nationwide simulation exercise in July 2025 to support the update of its National Influenza Pandemic Preparedness Plan (2019). This followed a PRET‑based virtual orientation and mini‑simulation exercise held in May 2025 by SEARO and the WHO PRET Secretariat. The comprehensive exercise, conducted across central and provincial levels, assessed strengths and gaps in pandemic influenza preparedness and response. The feedback gathered has been incorporated into the revised draft plan to address identified weaknesses and strengthen overall readiness.India conducted a targeted nationwide online re‑orientation training on review and updates to the influenza portal for all State Surveillance Officers (SSOs) and relevant officials using the Integrated Health Information Platform (IHIP). The training emphasized correct marking and reporting of influenza samples as “unsubtypable” or “not subtyped” where applicable, to ensure accurate national surveillance.Maldives conducted simulation exercises in three atolls based on its existing National Pandemic Preparedness and Response Plan (NPPRP). The country plans to conduct similar exercises in three additional atolls after updating the NPPRP in 2026. In addition, Maldives conducted training on FluID and FluMart as part of a broader data‑management training package for Ministry of Health and Health Protection Agency officials, aimed at improving routine reporting to WHO platforms and the DHIS2 system.In Myanmar, technical support was provided to the National Influenza Centre (NIC) through dedicated human‑resource support (January–December 2025) to sustain data management and laboratory detection capacity for influenza and other emerging and re‑emerging respiratory viruses. This support also included strengthening genomic sequencing capacity.Nepal conducted a consultative workshop on the National Pandemic Preparedness and Response Plan (NPPRP) in July 2025. The workshop engaged key stakeholders from multiple sectors to review lessons from past pandemic responses, assess current mechanisms, and gather critical inputs for strengthening national preparedness. Key recommendations included revising the 2019 NPPRP and developing an updated Influenza Pandemic Preparedness Plan aligned with emerging risks, national priorities, and relevant international frameworks. Nepal also held a two day workshop dedicated to advancing the National Action Plan for Genomic Surveillance, aimed at reinforcing the country’s capacities for early detection and monitoring of emerging respiratory pathogens.Sri Lanka received the final report from WHO on the feasibility assessment for conducting an Influenza Burden of Disease (BoD) study in the country. The assessment, conducted from 28 April to 9 May 2025, included a desk review of existing data sources, document review, visits to sentinel surveillance sites, and key informant interviews. The study identified critical data sources required for a future BoD assessment, as well as their availability and quality. Officials from the Epidemiology Unit, the National Influenza Centre (NIC), and SARI/ILI sentinel hospitals across the country participated in the assessment.Timor Leste conducted on‑the‑job training and monitoring activities at two sentinel surveillance sites to strengthen surveillance and laboratory capacity for the detection of SARI, ILI, ARI, and other respiratory infections. REGIONAL OFFICE:SEARO conducted a Member States Consultation on the first draft of the Regional Roadmap and Strategic Action Framework for implementing WHO’s PRET‑based broad respiratory pathogen pandemic planning for 2026–2031. The consultation took place on 29–30 October 2025 during the final two days of the Regional PIP PC Annual Review and PRET Meeting in Colombo, Sri Lanka. Participants included representatives from Member States, WHO Country Offices, WHO SEARO, WHO Headquarters, partner agencies, and invited multidisciplinary technical experts. They reviewed the draft and provided detailed feedback, which has since been incorporated into a revised version. The consultation helped shape a shared regional vision for robust, PRET‑aligned pandemic preparedness, building on country‑level progress, addressing existing gaps and challenges, and aligning with global and regional health security frameworks. The publication is planned for release during the SEAR regional committee in 2026.SEARO documented the evolution of the National Influenza Pandemic Preparedness Planning process in the Region, tracing its development from its origins as a planning tool for responding to avian influenza outbreaks in 2006, through the experiences of the 2009 and 2019 pandemics, to the current status. The document outlines the way forward for respiratory pathogen pandemic planning across all 10 SEAR countries, aligning future national plans with WHO’s PRET Framework for broad respiratory pathogen pandemic preparedness.The Infectious Hazard Management (IHM) Unit has drafted the WHO South‑East Asia Regional Guidance on Influenza Prevention and Control, aligned with the Global Influenza Strategy and other regional initiatives. The draft is currently under review. Although this technical product was developed in response to a request from the Ministry of Public Health of the Democratic People’s Republic of Korea (MoPH‑DPRK), SEARO is finalizing it for use not only in DPRK but also across all Member States in the Region.The Immunization and Vaccine Development (IVD) Unit, in collaboration with WHE/SEARO, completed a regional landscape analysis on key barriers, challenges, and opportunities for the introduction of seasonal influenza vaccination in WHO South‑East Asia Regional (SEAR) countries.Additionally, the Immunization and Vaccine Development (IVD) Unit has completed a regional landscape analysis of influenza vaccine procurement systems across the WHO South‑East Asia Region (SEAR).KEY MEETINGS AND PUBLICATIONSMEETINGS:Six-month progress review of the implementation of the PIP-PC workplans in SEAR, focusing on Outputs 1 and 2 for the period January to June 2025, and held virtually across three sessions on 4, 8, and 10 July 2025. Read moreAnnual Regional Meeting (Hybrid) on Pandemic Influenza Preparedness (PIP) Partnership Contribution (PC) and WHO’s Preparedness and Resilience for Emerging Threats (PRET) Implementation in SEAR in Colombo, Sri Lanka, 27 to 30 October 2025. Read more18th Bi-regional Meeting (Virtual) of National Influenza Centres (NICs) and influenza surveillance in WHO South-East Asia and Western Pacific Regions from 9 to 11 September 2025. Read morePUBLICATIONSImplications of influenza A virus surveillance in Southeast Asian Region countries: a scoping review of approaches for the surveillance of swine influenza viruses at human-swine interfaces. Read moreAnnual South-East Asia regional meeting on operational planning for implementation of global influenza strategy and preparedness for respiratory viruses in 2025 Report on annual review meeting of implementation of pandemic influenza preparedness (PIP) partnership Contribution (PC) Fund in South-East Asia Region and the simulation exercise on PRET Status of influenza in who south-East Asia Region
Louisiana reaches $45 million settlement with CVS Health, ending lawsuits
The state had accused CVS Health of “unfair, deceptive and unlawful” business practices for using customer information to conduct a text message campaign last year against proposed legislation for pharmacy benefits managers.
Healthcare E-Commerce Market Report 2026-2035: A $1.12 Trillion Market by 2030, Driven by Rural E-commerce, Tech-health Partnerships, Home Healthcare, Telemedicine, Demand for Cost-effective Products
Key opportunities in healthcare e-commerce include rising internet use, expanding e-pharmacies, digital healthcare awareness, AI integration, mobile health apps, personalized medicine, rural e-commerce, tech-health partnerships, home healthcare, telemedicine, and demand for cost-effective products. Healthcare E-Commerce Market Healthcare E-Commerce Market Dublin, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The "Healthcare E-Commerce Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Seattle Reign FC Announces Multi-Year Sponsorship with CVS Health
Purpose-driven sponsorship unites two organizations in advancing health and wellbeing through sport; CVS Health to serve as the club’s right sleeve partner and exclusive retail and community pharmacy partner of Seattle Reign FC Seattle Reign FC today announced a new multi-year sponsorship with
CVS Pharmacy community health partnership with U.S. Soccer and National Women's Soccer League
CVS Pharmacy partners with the U.S. Soccer Federation and the National Women's Soccer League to support community health through soccer initiatives.
New Expedition 74 Foursome Kicks off Science, Gets Used to Space
Vein scans and pharmaceutical research topped the science schedule aboard the International Space Station on Wednesday. The Expedition 74 crew rounded out the day with Dragon cargo transfers, lab familiarization activities, and life support maintenance duties.
Vanderbilt Health remembers C. Leon Partain, former chair of Radiology
Clarence Leon Partain, MD, PhD, professor emeritus of Radiology and Radiological Sciences, whose work in nuclear medicine and magnetic resonance imaging helped shape the field of academic radiology, died Jan. 28 in Brentwood, Tennessee. He was 85. After beginning his career as a nuclear engineer at Oak Ridge National Laboratory and as faculty at the University of Missouri and the University of North Carolina, Dr. Partain joined the ranks at Vanderbilt Radiology in 1980 and was promoted to professor in 1984. He later became the first Carol D. and Henry P. Pendergrass Professor of Radiology and Radiological Sciences and chair of the department (1992-2000), and subsequently the director of the Center for Imaging Research. Shortly after arriving in Nashville, Dr. Partain began to lead Vanderbilt Radiology’s nuclear medicine division. He remained in this role until he was named the department chair. Dr. Partain specialized in multiple fields, including nuclear medicine, magnetic resonance imaging and positron emission tomography. Following his time as chair, Dr. Partain shifted his focus to research and spent time working clinically with radiology’s chest imaging section. In 2015, he retired and was honored for his years of service and named as emeritus faculty. Dr. Partain also held an appointment as professor of Biomedical Engineering. A Tennessee native, Dr. Partain was born in Memphis and later graduated from high school in Clarksville. He then received his BS in nuclear engineering from the University of Tennessee, his MS and PhD in nuclear engineering from Purdue University and his MD from Washington University. He completed his residency training in diagnostic radiology and nuclear medicine at the University of North Carolina. Dr. Partain was clinically trained and certified in diagnostic radiology and nuclear radiology by the American Board of Radiology (ABR) and the American Board of Nuclear Medicine. Throughout his career, Dr. Partain contributed to the growth of Vanderbilt Radiology and received many academic and research accolades across the specialty through various associations. During his time leading the department, clinical studies increased from 180,000 to 260,000 cases per year, emerging technological imaging equipment expanded the department’s capabilities, and units for angiography and fluoroscopy were added to the tool kit. The department also expanded its footprint with outpatient imaging in Nashville, Bedford County and more. Research continued to expand with continued growth in scientific findings and millions in grant funding for radiopharmaceuticals, functional MRI, nuclear medicine, X-ray, ultrasound and more. Dr. Partain is celebrated for being instrumental in bringing the first MRI and PET/CT machines to the Medical Center. His efforts helped build Vanderbilt Radiology’s prestige in the world of academics and research both nationally and internationally. His society affiliations included the American College of Radiology, the American College of Nuclear Medicine, and the International Society of Magnetic Resonance in Medicine (ISMRM). He served as president of the Radiological Research Alliance of the Association of Academic Radiologists and has held executive roles as a member of many radiological society boards. Dr. Partain was editor-in-chief of the Journal of Magnetic Resonance Imaging from 2000 to 2013 and a member of the editorial boards of Magnetic Resonance in Medicine, Magnetic Resonance Imaging, the American Journal of Roentgenology, Academic Radiology, the Journal of Nuclear Medicine and Investigative Radiology. He has authored/co-authored/edited six textbooks, including one of the first comprehensive textbooks on MRI, “Nuclear Magnetic Resonance (NMR) Imaging.” Dr. Partain has also authored/co-authored/edited approximately 100-plus book chapters and 200-plus journal articles. In 2000, Dr. Partain received the Distinguished Service Award from the ABR. In 2014, he received the Distinguished Service Award from the ISMRM. In 2016, he received the Alumni Achievement Award from Washington University for his “contributions to advance the fields of nuclear medicine and medical imaging.” Dr. Partain served the ABR as an examiner for 20 years, the Accreditation Council for Graduate Medical Education as a member of the Nuclear Medicine Residency Review Committee, and Vanderbilt University School of Medicine in multiple capacities. A devout Baptist deacon and man of committed faith, he is survived by his wife of 62 years, Judy; children, David (Rebecca), Teri (Bland), and Amy; brother, Larry (Deb); brother-in-law, Tom (Cathy); grandchildren, Sarah (Brandon), Amy, Luke, Tucker, Alex, Ryan and Jake; cousins and a host of nieces and nephews. Vanderbilt Health is grateful to Dr. Partain for his decades of service and major contributions to clinical and research imaging.
Morgan Stanley Maintains Equal Weight on Phibro Animal Health Corporation (PAHC), Cites Margin Expansion
Phibro Animal Health Corporation (NASDAQ:PAHC) is among the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. The seventh stock on our list of cheap pharmaceutical stocks is Phibro Animal Health Corporation (NASDAQ:PAHC). TheFly reported on February 6 that Morgan Stanley increased its price target on PAHC to $49 from $45 and maintained an Equal Weight rating. […]
5 Questions to Ask Your Pharmacist at Your Next Visit
When you’re prescribed a medication, it’s important to understand why you’re taking the drug and how to take it. Learn what you should ask your pharmacist.
Scientists Discovered An Organism That Can Become Two Different Life Forms
Knowing which genes are responsible for the transformations could help with developing antifungal treatments, and may have other pharmaceutical and industrial applications.
Building biopharma: The communities behind the science
Editor’s note: This is the first of a twice-monthly series that will highlight the vibrant communities that make up the biopharma industry. | What began as a small summit of women biotech CEOs five years ago has grown into a 350-member force gaining momentum, even as political headwinds force others to retreat.
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of autoimmune and inflammatory diseases, today announced that Lucinda Warren, who has served as Cue Biopharma’s chief business officer (CBO) since September 2024, has been appointed chief financial and business officer (CFBO) effective February 9, 2026
Gov. Lujan Grisham named to 2026 TIME100 Health list
Lujan Grisham joins federal health care officials, pharmaceutical CEOs, scientists, researchers, actors and performers on the list.
Opinion | Modernizing these laws could expand access to health care for millions
Pharmacists in many states remain legally prohibited from providing care they are trained to deliver.
Gov. Michelle Lujan Grisham named on the 2026 TIME100 Health list
Lujan Grisham joins federal health care officials, pharmaceutical CEOs, scientists, researchers, actors and performers on the list.
Amazon Pharmacy to expand same-day prescription delivery to 4,500 US cities
Amazon plans to expand same-day prescription delivery to nearly 4,500 US cities by 2026, adding 2,000 communities and expanding savings programs.
CVS Health Q4 Earnings Call Highlights
CVS Health (NYSE:CVS) highlighted what executives described as a year of operational and financial progress during the company’s fourth-quarter 2025 earnings call, while also addressing industry cost pressures, Medicare Advantage funding concerns, and the evolving regulatory backdrop for pharmacy be
Innovation District hosts industry-informed life science skills course to support Virginia’s growing workforce needs
Throughout Virginia, the life sciences sector is gaining momentum as major pharmaceutical companies invest billions in new facilities and operations. As a result, employers need to find people who can step into laboratory and manufacturing roles right away. George Mason University's Innovation District is meeting the demand.
Walmart boosts pay potential for some pharmacy staff, college degree not required
Walmart is expanding higher-paying pharmacy roles and creating new leadership opportunities that allow workers to advance through training rather than a college degree.
NFL Alumni Health Partners with Wellgistics Health to Deploy Technology to Improve Health Outcomes for Former NFL Players and Rural Communities
Wellgistics Health to leverage EinsteinRx™ AI pharmacy hub and PharmacyChain™ smart contracts to drive healthcare
San Diego County health workers strike expands as over 500 pharmacy employees join picket lines
The Weight-Loss Price Wars Are Breaking Big Pharma’s Business Model
Prices for GLP-1s are falling fast, forcing companies to adapt.
Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department
The FDA said it would take “decisive steps” to restrict nonapproved drugs that use GLP-1 active pharmaceutical ingredients.
New recall includes nearly 23K bottles of triglycerides drug used to treat heart disease
New Jersey-based Zydus Pharmaceuticals has recalled nearly 23,000 bottles of its icosapent ethyl capsules due to leakage issues that may have weakened their effectiveness.
Maryland Companies Celebrate Global Collaborations, Industry Honors and Local Partnerships
The Maryland Marketing Partnership, which helps drive Maryland's branding and marketing efforts to attract businesses, create jobs, and grow the state's economy, today shared a summary of the latest news from companies and organizations that invest in the partnership. "Maryland's marketing partners are starting the year with major investments in our state's workforce and economy," said Harry Coker Jr., Secretary for the Maryland Department of Commerce. "From clean energy to biopharma to higher education to commercial real estate, these investments are helping us build a stronger and more competitive Maryland economy." BGE , Maryland's largest natural gas and electric utility, along with the Exelon Foundation , announced a $250,000 grant for Civic Works' Baltimore Shines solar initiative to support solar installations for 30 homes in Baltimore. According to Civic Works, homeowners will receive free rooftop solar installations, adding clean energy to the grid and generating more than
Xtalks Announces its Life Science Webinar Calendar for February 2026
Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!
PBMs hit by Trump transparency rule
Drug supply chain middlemen would have to disclose financial dealings with drugmakers, pharmacies and others.
DHL Health Logistics Singapore Expands Capabilities to Elevate Life Science & Healthcare Logistics
DHL Group has announced the expansion of its life sciences arm—DHL Health Logistics—with the development of a €10 million Pharmaceutical Hub in Singapore. This investment bolsters regional Life Sciences and Healthcare (LSHC) infrastructure.
RFK Jr. is now a wellness guru for Republicans in Washington
Conservatives in the capital are taking up the health secretary’s advice, eating their vegetables and eschewing pharmaceuticals.
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
SHANGHAI, February 01, 2026--GAH and Tenacia announce a China commercialization partnership for ZTALMY, the first approved therapy for CDKL5 deficiency disorder.
CVS Health Faces Antitrust Scrutiny As Valuation Flags Undervaluation Risk
U.S. House Judiciary Committee alleges CVS Health restricted independent pharmacies from using competing digital pharmacy hubs. The investigation cites cease and desist letters and network rule changes as potential antitrust issues. CVS Health disputes the findings and says some policies have been revised. For investors watching CVS Health (NYSE:CVS), the focus is shifting to regulatory risk around how its pharmacy network operates. The company’s shares closed at $74.52, with a return of...
Why some on Medicaid in NJ may need to find a new pharmacy
CVS Pharmacy sites are to remain in-network for people using Medicaid only through April 30.
Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive disorders
Neuropsychopharmacology - Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive...
Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive disorders
Neuropsychopharmacology - Fundamentals of healthcare delivery science for the non-health systems scientist: the final step in translational research for late-life psychiatric and neurocognitive...
Tanzania eyes East Africa’s pharmaceutical hub crown {Business Africa}
Tanzania is betting on local drug manufacturing to reduce imports and become East Africa’s pharmaceutical hub and we find out how Africa's private sector is fixing the supply chain to minimise the billions lost in post-harvest logistics.View on euronews
‘Where Science Meets Patient Care’: URI College of Pharmacy to host 41st annual Seminar By the Sea
KINGSTON, R.I. — Jan. 29, 2026 — Pharmacists from around the region will earn valuable continuing education credits while discussing some of the most pressing current pharmacy and healthcare issues during the 41st annual Seminar By the Sea Northeast Regional Conference presented by the University of Rhode Island College of Pharmacy’s Office of Healthcare Workforce […]
Xevant Named a 2025 Modern Healthcare Best in Business Company for AI
Xevant, a leader in real-time pharmacy benefits intelligence, today announced it has been named a 2025 Modern Healthcare Best in Business company in the Artificial Intelligence (AI) category. The recognition honors healthcare suppliers and technology partners whose innovations delivered measurable impact across the healthcare ecosystem in 2025.
Sheldon Kasowitz Champions Science-Based Solutions for Addiction
For Kasowitz, the motivation is deeply personal and urgent
The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders
Neuropsychopharmacology - The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders
‘It’s a hospitality-wide problem‘: night-time traders react to business rates relief plan
Gyms, pharmacies, restaurants and cafes and convenience store owners question why only pubs and live music venues should get help
5 Key Moments from Ways and Means Committee Hearing with Health Insurance CEOs
CEOs of the nation’s largest health insurers and pharmacy benefit managers (PBMs) appeared before the Ways and Means Committee to...
Redding, Anderson Walmart stores to offer free health checks, products
Here's when and how to get free product samples, blood pressure and glucose checks, vision screenings and more at California Walmart pharmacies.
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / January 9, 2026 / RedChip Companies will air interviews with Alliance
CVS Health (CVS) Valuation Check As Regulatory Scrutiny And Legal Outcomes Draw Investor Focus
Regulatory and legal scrutiny is back in focus for CVS Health (CVS), as a U.S. House Judiciary Committee probe into its pharmacy benefit manager practices unfolds, while a separate class action over prescription drug pricing has been dismissed. See our latest analysis for CVS Health. For context, CVS Health shares now trade at US$82.68, with a 30 day share price return of 5.95% and a year to date share price return of 3.18%, while the 1 year total shareholder return of 59.48% reflects how...
NextCure Provides Business Update
SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohorts BELTSVILLE, Md., Jan. 23, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today provided updates for its two antibody drug conjugate (ADC) programs and reported a preliminary year-end 2025 cash position. SIM0505 (CDH6 ADC): Phase 1 dose e
How biopharma R&D can close the gender health gap
The structural and systemic drivers of health disparities between women and men are well documented. Biopharma R&D can close these gaps, powered by recent advances in science, technology and data.
Takeda inks big expansion at former Motorola Mobility campus
The pharmaceutical giant is beefing up its distribution space at Innovation Park Lake County, a win for the Chicago developer that bought it just more than a year ago.
Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. | While much of the biopharma industry has spent the past 12 months treading lightly around the Trump administration and the tumult it has wrought on U.S. medical research and regulation, Pfizer’s CEO cut to the chase this week in a blatant rebuke of HHS secretary Robert F. Kennedy Jr., according to The Wall Street Journal.
House Appropriations Committee releases health funding proposal
The House Appropriations Committee has unveiled proposed outlays for the Department of Health and Human Services (HHS), including key investments in priorities within the Make America Healthy Again | The House Appropriations Committee has unveiled proposed outlays for the Department of Health and Human Services, including key investments in priorities within the Make America Healthy Again movement and long-discussed pharmacy benefit manager oversight.
Another alliance of health care and AI signals why pharma stocks should be back in favor
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating early detection of lung cancer.
Video Tips to better manage your health in the new year
Tanvi Patel, vice president and general manager of Amazon Pharmacy, a “GMA” sponsor, shares tips to set your health up for success in the new year.
Cone Health Names System-wide Chief Pharmacy Officer
Kristen Kruszewski brings more than 20 years of pharmacy experience to the role.
JPM26: Chugai chases new science and name recognition from US biopharma industry
The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. Morgan Healthcare Conference in San Francisco, they’re working hard to change that while also seeking out new science to bring into their storied drug discovery operation.
3SBio Sees More Business Development Deals
Tony He, CFO of the Chinese biopharmaceutical firm 3SBio, discusses his outlook for dealmaking and the progress of a record licensing deal the company struck with Pfizer last year. He speaks on “Bloomberg: The China Show” from San Francisco, where the JPMorgan Healthcare Conference is taking place. (Source: Bloomberg)
Local independently owned pharmacy provides gender-affirming care after UW Health pause
FITCHBURG, Wis.- After UW Health, one of the state's largest hospitals, announced it's pausing its gender-affirming care citing "recent federal actions,” a local, independently owned pharmacy is stepping up to
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
Biopharma companies—including AstraZeneca, BioNTech and Agios—peered farther into the future on the second day of JPM, setting both revenue and R&D targets through the end of the decade.
Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill
In recent days, Amazon Pharmacy announced it would begin offering Novo Nordisk’s Wegovy once-daily weight-loss pill through both insurance and cash-pay channels, including future availability via its pharmacy kiosks. This move directly targets the fast-growing weight management segment where Hims & Hers Health participates, raising fresh questions about how differentiated and resilient its broader telehealth platform and recurring-care model really are beyond GLP-1 offerings. We’ll now...
Scoop: Dems make health deal offer with ACA subsidies
There's bipartisan sentiment to address long-stalled priorities like pharmacy benefit manager business practices.
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
ORLANDO, FLORIDA / ACCESS Newswire / January 9, 2026 / RedChip Companies will air interviews with Alliance
Health Care Roundup: Market Talk
Find insight on China’s biopharmaceutical companies in the latest Market Talks covering the health care sector.
Healthy Returns: What to expect from pharma at the JPM conference
At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy M&A deals.
The Weight-Loss Drug Revolution—From Shots to Pills and the Science behind It All
Behind the hype of GLP-1 medications lies complex science, serious side effects and a pharmaceutical arms race.
Walmart’s New Better Care Digital Health Push Could Be A Game Changer For Walmart (WMT)
Earlier this month, Walmart launched Better Care Services, a digital health platform connecting customers to third-party urgent and behavioral care providers, nutrition tools, and discounted telehealth, while also expanding wellness assortments and hosting nationwide wellness events across nearly 4,600 pharmacies. At the same time, Walmart strengthened its technology focus by adding longtime tech leader Shishir Mehrotra to its board and broadening AI-powered, wellness-linked offerings that...
More businesses call to be included in pub rates backtrack
High street shops, pharmacies and music venues have said that the axing of planned increases to business rates for pubs should apply to them too.
NYC Health + Hospitals/Gotham Health Launches Pharmacy Home Delivery Program Across New York City - NYC Health + Hospitals
New York, NY — NYC Health + Hospitals/Gotham Health today announced the launch of its Pharmacy Home Delivery Program, now available at all 29 Gotham
WellSpan Health Announces Comprehensive Migration of Technology Portfolio to AWS
Add to FavoritesWellSpan Health, the leading health care system serving Central Pennsylvania and Northern Maryland, today announced plans for a comprehensive cloud migration of its full technology infrastructure. Together with Amazon Web Services (AWS) as its preferred cloud provider, WellSpan will transition its applications, data and environments from traditional data centers to AWS. This migration will establish the foundation for delivering next-generation, AI-enabled health care solutions that reduce administrative burden and improve outcomes for patients across the region and beyond. Supercharging Innovation, Efficiency and Patient Outcomes WellSpan's migration of systems and clinical applications, which serve 1.2 million patients across nine hospitals and 250+ facilities, is expected to be complete by April 2026, one of the fastest full-scale migrations in the health care industry. This transformation enables WellSpan to unify disparate data systems for care teams and patients alike, achieving operational efficiencies and care improvements that fragmented systems are unable to deliver. “Our comprehensive migration to the cloud accelerates our ability to deploy new clinical capabilities that transform patient care while advancing our overall innovation strategy,” said Roxanna Gapstur, Ph.D., R.N., president and CEO, WellSpan Health. “When a physician can access complete patient imaging in seconds instead of hours, we're not just modernizing technology—we're improving patient outcomes. Our new cloud infrastructure also enables us to quickly implement solutions that will free our clinicians from thousands of hours of administrative work annually so they can focus on what they do best: caring for our communities.” The transition allows WellSpan to move away from a data center-based model and enables the rapid deployment and scale of AI technology. WellSpan’s strategic partner, General Catalyst’s Health Assurance Transformation Company (HATCo), facilitated the collaboration with AWS to support the migration. WellSpan’s transformation journey benefits from HATCo’s specialized technology solutions, as well as General Catalyst and AWS’s significant partnership to improve patient outcomes, which was announced in January 2025. “Our decision to go all-in on AWS will enable insights and innovations impossible in traditional siloed environments,” said Kasey Paulus, executive vice president and chief operating officer, WellSpan Health. “This is the largest health care technology transformation in our region's history, and it positions WellSpan to be a premier partner for technology leaders across the country.” “WellSpan is building a foundation with AWS that will improve care and outcomes for patients across their health system by bringing data together into standardized formats that are optimized for AI applications,” said Dan Sheeran, vice president and general manager, Healthcare and Life Science, AWS. “To do this, it is essential to have the most secure and compliant cloud when handling patient data, along with AWS’s built-in AI governance and responsible AI frameworks that follow the industry’s highest standards to protect patient information. We look forward to continuing to work alongside WellSpan as they unlock the cloud and AI’s full potential to deliver exceptional care to their patients.” Key Benefits of the AWS Collaboration Full Portfolio Migration: WellSpan will transition its applications and data from on-premises data centers to AWS, including full IT environments and specialized applications for functions such as nursing, cardiology, pharmacy and the company’s supply chain systems. This represents approximately 7.5 petabytes of clinical and non-clinical data and more than 300 applications—the most comprehensive health system cloud migration in the Mid-Atlantic region. Approved Architectures: AWS will deliver secure, WellSpan-specific architectures tailored to each build, ensuring compliance and reliability across the health system. Unified, AI-Ready Data: Migrating to AWS enables WellSpan to harmonize data across separate systems, transforming unstructured clinical notes and multi-modal datasets into standardized, AI-ready formats. Accelerated Results and Improved Outcomes: Automated data normalization and processing will enable the deployment of applications that reduce turnaround times for items such as analyzing medical imaging or patient records from days to minutes, helping clinicians get patient results faster and improving overall health outcomes. Reduced Administrative Burden: The transition to AWS will enable swift deployment of AI-powered solutions that reclaim thousands of hours for WellSpan’s clinical and corporate teams, allowing them to focus on patient care rather than paperwork. Elastic Infrastructure: Cloud architecture will enable WellSpan to scale computing resources dynamically, supporting seasonal demand fluctuations without infrastructure investments, as well as the rapid deployment of new services across multiple locations simultaneously. Most Secure, Compliant Cloud: AWS offers the highest network availability of any cloud provider, with more than 166 HIPAA-eligible services and certifications for global compliance standards, including HITRUST CSF. Built-in AI governance and responsible AI frameworks ensure that WellSpan’s data is protected under the industry’s most rigorous standards. Tags:News releaseInnovation and partnerships
Science 37 Named Finalist in Two Categories for the 2026 SCOPE Awards
MORRISVILLE, N.C., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, today announced it has been named a finalist for two prestigious SCOPE Awards: the Participant Engagement Award and the Site Innovation Award. This marks the first time that a single company has been named a finalist for two SCOPE Award categories in the same year. Driving Engagement Through Community Pharmacies Science 37 was recognized for the Participant Engagement Award
The new science and business of oral biologics
Biologics are built for precision. The gastrointestinal tract is built for demolition. Between stomach acid, digestive enzymes, and the physical barricade of the intestinal wall, most large molecules do not merely struggle to get absorbed. They get dismantled.
Wegovy obesity pill now available at pharmacies
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.
A Healthy Gut Could Improve Mental Health
New research explores the gut-brain connection, suggesting that improving gut health may enhance mental well-being.
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
Trump announces deals with nine drug companies, aiming to lower cost of medicine
In his latest effort to lower drug costs, President Donald Trump unveiled Friday “Most Favored Nation” pricing deals with nine more pharmaceutical companies.
Trump secures agreements with major drugmakers to lower Medicaid prescription costs for Americans
President Donald Trump announced Friday that nine additional pharmaceutical companies joined its most-favored-nation pricing initiative.
Vertex Forward: Our animated video series
Watch the animated video series “Vertex Forward” to see the Vertex Pharmaceuticals philosophy and strategy explained.
A Game Plan for Sports Health
Hayden Lee’s journey from high school athlete to Pharmacy/MBA student at Cedarville University reveals how his passion for sports and science ignited a career path in...
House passes narrow health care package; sets up a vote on EPTCs in January
The House yesterday passed the Lower Health Care Premiums for All Americans Act (H.R. 6703), legislation to expand association health plans, increase transparency requirements for pharmacy benefit managers, and fund cost-sharing reductions for some Health Insurance Marketplace enrollees. The measure advanced by a 216-211 vote and will now move to the Senate for consideration.
Dr. Quidley appointed to SCCM Bedside Care team
Dr. April Quidley will contribute to the development of a critical care training program with a focus on pharmacy intervention
UnitedHealthcare delays controversial RPM policy change
In this edition of STAT Health Tech: United Healthcare delays a key policy change, State AGs write to Meta about misleading pharma ads, and more.
Insmed Provides Clinical and Business Update
/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to...
Insmed Provides Clinical and Business Update
Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, announced today that the Phase 2b BiRCh study of brensocatib in patients with chronic rhinosinusitis without nasal polyps (CRSsNP) did not meet its primary or secondary efficacy endpoints in either the 10 mg or 40 mg treatment arms. Brensocatib was well tolerated, with no new safety signals identified
Michigan pharmacist sentenced to prison for $6M health care fraud scheme
How NIH-Funded Science Supports US Biopharmaceutical Innovation
NIH-funded research supports the foundation for industry to develop vaccines and therapies, exemplifying deep public-private R&D complementarity. As global competition intensifies, expanding NIH funding will be key to protecting American health, supporting U.S. biopharmaceutical competitiveness, and ensuring national power and security.
How Bayer transforms Pharma R&D with a cloud-based data science ecosystem using Amazon SageMaker
In this post, we discuss how Bayer AG used the next generation of Amazon SageMaker to build a cloud-based Pharma R&D Data Science Ecosystem (DSE) that unified data ingestion, storage, analytics, and AI/ML workflows.
OpenAI exec identifies 3 jobs that are not AI proof
"My bet is often on life sciences, pharma companies," Olivier Godement said.
Rogers Victor: Food, not pharma: A new path for Michigan’s health
"Food is Medicine" is an important movement, but only a culture-wide shift will turn around our poor diet-driven health trajectory.
SPONSORED Novartis makes $23 billion investment in America's health
Ten facilities – including seven new sites – will create thousands of jobs and accelerate U.S. pharmaceutical innovation.
Agora Open Science Trust Announces Nomination of M4K2009 as Lead Development Candidate for Pediatric Brain Cancer Therapy
TORONTO, December 08, 2025--Agora Open Science Trust today announced the nomination of M4K2009 as the lead development candidate for its M4K Pharma program, which applies open science to drive the development of an affordable treatment for Diffuse Intrinsic Pontine Glioma (DIPG), a rare and devastating pediatric brain cancer. Nominating a lead development candidate marks the point where a discovery program selects a single molecule with the highest potential to advance further towards human clin
UK University Health Pharmacy closing Dec. 19
Patients are able to transfer their prescriptions to another UK Retail Pharmacy location through an online form.
Aspire Biopharma Provides Q3 2025 Business Update
ESTERO, FL / ACCESS Newswire / December 4, 2025 /Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today provides a business update for the quarter ended ...
Holland & Knight Health Dose: December 3, 2025 | Insights
The Trump Administration finalized a trade agreement with the UK that exempts British-origin pharmaceuticals, ingredients and medical technology from Section 232 tariffs.
Improving Community Health Through Project Health
While visiting her local CVS Pharmacy, a woman walked by a Project Health event happening in-store. Interested, she decided to take advantage of the free health screening offered there. What began as a simple shopping trip quickly turned into a moment of motivation.
Yuyu Pharma Announces Strategic Investment in Dalan Animal Health as Part of Accelerated Global Expansion in Animal Health
Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector.
Top 10 Healthcare Industry Predictions For 2026
Sachin Jain’s annual list of health industry predictions covering managed care, hospitals, pharma, digital health, and entrepreneurship.
Walmart amazing Cyber Monday deal on this top-rated laptop is only $109
The Chromebook has over 7,400 five-star reviews.
Physician-led care is best prescription for health of nation
Allowing pharmacists to diagnose conditions and prescribe medications far exceeds their training and jeopardizes patient health.
Opterion Health AG Announces Appointment of Andreas Schuh as Chief Financial Officer
MUTTENZ, Switzerland, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Opterion Health AG, a clinical-stage biopharmaceutical company pioneering innovation in peritoneal dialysis (PD), is pleased to announce the appointment of Andreas Schuh as Chief Financial Officer (CFO), effective December 1, 2025. Andreas Schuh joins Opterion with over 20 years of leadership experience across biotech, pharma, and medical devices. He has held senior finance and operations roles at Nuclidium, Jeito, Roivant, Novartis, and Al
A pharmacist says she'd only recommend one science-backed tweakment for radiant skin
Tweakements are non-surgical cosmetic procedures like injectables and lasers — and they're extremely popular.